Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid
- PMID: 1376558
- PMCID: PMC1886549
Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid
Abstract
The presence of extracellular deposits of beta-amyloid protein in the brain is a hallmark of Alzheimer's disease (AD). In an effort to determine the effect of amyloid in an animal model, the authors injected amyloid cores isolated from AD brains into the cortex and hippocampus of rats. Lipofuscin, a major contaminant of the plaque core preparation, was injected on the contralateral side and used as a control to induce an analogous phagocytic cell response. Rats were sacrificed 2 days, 7 days, and 1 month after injection and amyloid located by four histochemical techniques. Amyloid and lipofuscin move from the site of injection into otherwise undamaged neuropil, persist for at least 1 month and are both associated with increases in glial fibrillary acidic protein and microglia (OX-42) staining. By 1 week, many of the amyloid cores are ingested by phagocytes. Some of the beta-amyloid-containing phagocytes migrate to the vessels and to the ventricles, and by 1 month, a significant amount of the amyloid is directly associated with the vessels. This suggests that phagocytic cells can internalize exogenous amyloid and attempt to clear it from the central nervous system (CNS). Therefore, the observed distribution of amyloid is not necessarily the initial site of deposition.
Similar articles
-
Effects of injected Alzheimer beta-amyloid cores in rat brain.Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8362-6. doi: 10.1073/pnas.88.19.8362. Proc Natl Acad Sci U S A. 1991. PMID: 1924295 Free PMC article.
-
ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.J Alzheimers Dis. 2016 Sep 6;54(2):569-84. doi: 10.3233/JAD-160456. J Alzheimers Dis. 2016. PMID: 27472885
-
Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.Biotech Histochem. 2001 Mar;76(2):97-106. Biotech Histochem. 2001. PMID: 11440311
-
Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.Eur J Neurosci. 2007 Nov;26(9):2458-68. doi: 10.1111/j.1460-9568.2007.05852.x. Epub 2007 Oct 23. Eur J Neurosci. 2007. PMID: 17970733
-
Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.Am J Pathol. 1993 May;142(5):1449-57. Am J Pathol. 1993. PMID: 7684195 Free PMC article. Review.
Cited by
-
A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease.Front Physiol. 2019 Oct 24;10:1269. doi: 10.3389/fphys.2019.01269. eCollection 2019. Front Physiol. 2019. PMID: 31708792 Free PMC article.
-
Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.J Clin Invest. 2006 Nov;116(11):3060-9. doi: 10.1172/JCI27341. J Clin Invest. 2006. PMID: 17080199 Free PMC article.
-
Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.Am J Pathol. 1998 Sep;153(3):725-33. doi: 10.1016/s0002-9440(10)65616-7. Am J Pathol. 1998. PMID: 9736023 Free PMC article.
-
Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia.J Neurosci. 1997 Apr 1;17(7):2284-94. doi: 10.1523/JNEUROSCI.17-07-02284.1997. J Neurosci. 1997. PMID: 9065490 Free PMC article.
-
Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.J Neurosci. 2002 Mar 15;22(6):2246-54. doi: 10.1523/JNEUROSCI.22-06-02246.2002. J Neurosci. 2002. PMID: 11896164 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources